| Trial ID: | L2642 |
| Source ID: | NCT01407289
|
| Associated Drug: |
Insulin Aspart, Insulin Glargine
|
| Title: |
A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulin Aspart, Insulin Glargine
|
| Outcome Measures: |
Primary: Mean blood glucose, Mean blood glucose over 24 hours, duration of hospital stay (48 hours - maximum three weeks) | Secondary: Number of glucose measurements in hyperglycaemic ranges, duration of hospital stay (48 hours - maximum three weeks)
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Graz
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
74
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-06
|
| Completion Date: |
2012-04
|
| Results First Posted: |
|
| Last Update Posted: |
2013-02-05
|
| Locations: |
Medical University of Graz, Division of Internal Medicine, Department of Endocrinology and Metabolism/ Cardiology, Graz, 8036, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01407289
|
